ENDOMETRIAL EXPRESSION OF RELAXIN AND RELAXIN RECEPTOR IN ENDOMETRIOSIS
article
OA: closed
CC0
AI-generated summary
This study investigated the expression of relaxin and its receptor RXFP1 in endometriosis and found that relaxin regulates MMPs and VEGF, which are overexpressed in the disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Relaxin is a peptide discovered since 1926 by Hisaw. Belongs to the super family of structurally related hormones including: relaxin-1, -2 and -3 and insulin-like (INSL) peptides 3, 4, 5 and 6 and has important roles in follicle growth and ovulation, in implantation of the egg, preparation of the endometrium for implantation, in uterine growth in pregnancy, in inhibiting the myometrium contractile activity, in the procession of lactation and also exerts a protective effect in endometriosis. The relaxin family peptides produce their physiological effects by activating a group of four G protein-coupled receptors, relaxin family peptide receptors 1-4 (RXFP1-4). Relaxin regulates the expression of matrix metalloproteinase's (MMPs), a group of enzymes that degrade the extracellular matrix, essential for invasion of endometrial cells in peritoneum and also the expression of the vascular endothelial growth factor (VEGF), a glycoprotein with vasculogenic regulatory role in endometriosis by determining an excessive angiogenesis. MMPs and VEGF are both over expressed in the ectopic endometrial tissue of patients with endometriosis. Blocking the production of VEGF and MMPs appear to be effective and specific means of treatment in endometriosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (34)
- Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis via openalex
- Metalloproteinases, vascular endothelial growth factor, and angiopoietin 1 and 2 in eutopic and ectopic endometrium via openalex
- Steroidogenic Enzyme and Key Decidualization Marker Dysregulation in Endometrial Stromal Cells from Women with Versus Without Endometriosis1 via openalex
- The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- W2034271916 via openalex
- W2041528083 via openalex
- W2041767365 via openalex
- W2069224480 via openalex
- W2085522770 via openalex
- W2089225173 via openalex
- W2105701716 via openalex
- W2109670863 via openalex
- W2115555378 via openalex
- W2117607600 via openalex
- W2122661016 via openalex
- W2125200790 via openalex
- W2127260487 via openalex
- W2132468662 via openalex
- W2136091185 via openalex
- W2137296801 via openalex
- W2137796923 via openalex
- W2144468109 via openalex
- W2145387518 via openalex
- W2151455724 via openalex
- W2154120641 via openalex
- W2160667315 via openalex
- W2166304313 via openalex
- W1538998422 via openalex
- W2271747465 via openalex
- W1965542378 via openalex
- W1985127594 via openalex
- W2001035620 via openalex
- W2018338056 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK